title: [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
authors: J
authors: J
authors: Cianciara
authors: T
authors: T
authors: Loch
authors: L
authors: L
authors: Babiuch
authors: B
authors: B
authors: Dabrowska-Bernstein
authors: A
authors: A
authors: Stasiak
authors: M
authors: M
authors: Dabrowski
authors: A
authors: A
authors: Pawińska
mesh_terms: D000328:Adult; D002986:Clinical Trials as Topic; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006513:Hepatitis B e Antigens / Q000032:analysis; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007288:Inosine / Q000031:analogs & derivatives*; D007542:Inosine Pranobex / Q000627:therapeutic use*; D008875:Middle Aged
chemical_list: D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D007288:Inosine; D007542:Inosine Pranobex
vernacular_title: Leczenie przewlekłego aktywnego zapalenia watroby (HBsAg +, HBeAg +) izoprynozyna. Ocena kliniczna.